Safety and efficacy of ciclosporin 1 mg/mL cationic emulsion (CsA CE) over 12 months in patients with severe dry eye disease (DED) in the SANSIKA Phase III trial

Van Setten Gysbert B.; Figueiredo Francisco C.; Leonardi Andrea; Amrane Mourad; Garrigue Jean-Sebasten; Ismail Dahlia; Baudouin Christophe

首页> 外文期刊>Investigative ophthalmology & visual science >Safety and efficacy of ciclosporin 1 mg/mL cationic emulsion (CsA CE) over 12 months in patients with severe dry eye disease (DED) in the SANSIKA Phase III trial

【24h】

Safety and efficacy of ciclosporin 1 mg/mL cationic emulsion (CsA CE) over 12 months in patients with severe dry eye disease (DED) in the SANSIKA Phase III trial

机译：Ciclosporin 1mg / ml阳离子乳液（CSA Ce）在梭湿眼病（DED）患者中12个月内阳离子乳液（CSA CE）的安全性和有效性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2016年第12期|共3页
作者
Van Setten Gysbert B.; Figueiredo Francisco C.; Leonardi Andrea; Amrane Mourad; Garrigue Jean-Sebasten; Ismail Dahlia; Baudouin Christophe;
展开▼
作者单位

Karolinska Inst St Eriks Eye Hosp Danderyd Sweden;

Newcastle Univ Royal Victoria Infirm Newcastle Upon Tyne Tyne &

Wear England;

Univ Padua Dept Neurosci Ophthalmol Unit Padua Italy;

Santen SAS Evry France;

Santen SAS Evry France;

Santen SAS Evry France;

Quinze Vingts Natl Ophthalmol Hosp Paris France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
专利

1. Safety and efficacy of ciclosporin 1 mg/mL cationic emulsion (CsA CE) over 12 months in patients with severe dry eye disease (DED) in the SANSIKA Phase III trial [J] . Van Setten Gysbert B., Figueiredo Francisco C., Leonardi Andrea, Investigative ophthalmology & visual science . 2016,第12期

机译：Ciclosporin 1mg / ml阳离子乳液（CSA Ce）在梭湿眼病（DED）患者中12个月内阳离子乳液（CSA CE）的安全性和有效性
2. Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies [J] . Andrea Leonardi, Elisabeth M Messmer, Marc Labetoulle, British journal of ophthalmology . 2019,第1期

机译：干眼症阳离子乳液0.1％Ciclosporin的疗效和安全性：两种双掩盖，随机，载体控制第三期临床研究的合并分析
3. Persistence of Efficacy of 0.1% Cyclosporin A Cationic Emulsion in Subjects with Severe Keratitis Due to Dry Eye Disease: A Nonrandomized, Open-label Extension of the SANSIKA Study [J] . Labetoulle Marc, Leonardi Andrea, Amrane Mourad, Clinical therapeutics . 2018,第11期

机译：持续0.1％环孢菌素阳离子乳液在具有干眼症的严重角膜炎的受试者中的阳离子乳液的效果：非扫描，开放标签延伸的梭景观研究
4. Assessment of the efficacy of topical cyclosporine for Dry Eye Disease induced by mustard gas using tear osmolarity measurement [C] . Jadidi K., Ebrahimi A., Rezaee M., International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：用泪液测量评估芥子气体诱导的芥子气体诱导的干眼症疗效的疗效
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Efficacy and safety of 0.1 ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked randomised vehicle-controlled phase III clinical studies [O] . Andrea Leonardi, Elisabeth M Messmer, Marc Labetoulle, -1

机译：0.1％环孢素A阳离子乳剂在干眼症中的功效和安全性：两项双重掩蔽随机载体对照的III期临床研究的汇总分析
7. Efficacy and safety of 0.1 ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies [O] . Andrea Leonardi, Elisabeth M Messmer, Marc Labetoulle, 2018

机译：干眼症阳离子乳液0.1％Ciclosporin的疗效和安全性：两种双掩盖，随机，载体控制第三期临床研究的合并分析

Safety and efficacy of ciclosporin 1 mg/mL cationic emulsion (CsA CE) over 12 months in patients with severe dry eye disease (DED) in the SANSIKA Phase III trial

著录项

相似文献

相关主题

期刊订阅